| P.O.Box 2345, Beijing 100023,China | China Nati J New Gastroenterol 1996 Jun 2;(2):106-108 |
| Email: wcjd@public.bta.net.cn | ISSN 1007-9327 CN 14-1219/ R |
| http:// www.wjgnet.com | Copyright © by The WJG Press |
P53
and PCNA expression in glandular dilatation of gastric mucosa
Yang
Kun Wang, Xiao Long Ji, You Gui Gu, Shu Chun Zhang, Jian He Xiao
Subject
headings
gastric mucosa; precancerous conditions; stomach neoplasms; adenocarcinoma; genes,
P53
Wang YK, Ji XL, Gu YG, Zhang SC, Xiao JH. P53 and PCNA expression in glandular
dilatation of gastric mucosa. China Nati J New Gastroenterol, 1996;2(2):106-108
Abstract
AIM To study the expression of
P53 and PCNA in relation to the gastric mucosa lesions.
METHODS S-P
immunohistochemical method was used to observe 92 samples of glandular
dilatation of gastric mucosa and 30 cases of adenocarcinoma of stomach.
RESULTS P53 showed no
expression in simple glandular dilatation, but with small number
of cell expression in atypical glandular dilatation <8.6% (5/58)£Y,and strong
expression in gastric glandular cancer <46.7% (14/30)£Y.
There were a small number of
PCNA positive cells in simple glandular dilatation, and a significant increase
of positive cells in atypical glandular dilatation (P<0.01), positive
cells were widely distributed and deeply stained in case of gastric cancer.
CONCLUSION It is suggested
that P53 and PCNA can be jointly used as an important criterion for diagnosing,
classifying and treating the precancerous lesions of gastric mucosa.
INTRODUCTION
In recent years, there have been many researches of the glandular dilatation of
gastric mucosa. It was proposed that some morphological forms of gastric
glandular dilatation should be related to gastric cancer; but there were
also articles stating that the cystic dilatation of various degrees in gastric
and pyloric glands is only a kind of alteration in the late stage of atrophic
gastritis[1-7]. The
glandular dilatation of gastric mucosa is commonly
seen in clinical pathology, so it is necessary to distinguish the types of
glandular dilatation, and find out the pathologic forms which are involved in
the cancerous
lesions. In this study, the S-Pimmunohistochemical
method was used for
comparison between 92 samples of different histologic types of glandular
dilatation and 30 cases of adenocarcinoma of stomach. The assessment of P53 and
PCNA expression is contributory to
the clinical treatment and the research of precancerous
lesions.
MATERIALS
AND METHODS
Totally 122 samples of gastric mucosa biopsy were observed. Of them, 92 were
gastric mucosa glandular dilatation and 30, the adenocarcinoma of stomach. The
patients
were aged in a range of 25-74 years, averaging 49.3
years. There were
72 males and 50 females. The samples were fixed
in 10% formalin, embedded in paraffin. The section was 5μm in
thickness, ordinarily with HE staining. Cell
morphology and tissue structure were observed.Immunohistochemical
staining was carried out by linking the streptomyces avidin
and peroxidase. AntiP53 monoclonalantibodies
(DO-7,
reacting to both wild and mutant protein), antiPCNA and instanttype
reagent boxes were all the products
of Maixi Biochemical Technology Company. DAB coloration and hematoxylin tinction
were used, with PBS serving as the first antibody to make negative comparison.
The positive reactions were graded into 4 grades according to the
number of brown particles appearing in cell nucleus: Ⅰ=0%25%, Ⅱ=26%50%, Ⅲ=51%75%, and Ⅳ=76%100%.
The simple and heterotype dilatations
were distinguishable, the latter included the cystadenomatoid and adenomatoid
atypical hyperplasia, in accordance with the degree, form and number of the
glandular dilatation, and the amount of mucus in the lumen of gland, the
presence of atypical epithelioglandular cells, as well as the accompanying
glandular atrophy and/or intestinal metaplasia,
etc.
RESULTS
Histopathology
Simple glandular dilatation was found in a small number of mild degree of focal
or isolated glandular dilatation, showing an increased amount of mucus in the
lumen of gland. The epithelioglandular cells were of monolayer pavement or
columnar in shape; there were no atypical alteration of epithelium and no
accompanying glandular atrophy and intestinal metaplasia.Atypical
glandular dilatation showed cystadeno
and adenomatoid atypical hyperplasia.
①- Cystadeno-atypical proliferation showed a lot of glandular hyperplasia
in cystic dilatation, in various degrees and forms, with possibly papillalike or branch-like
structures, irregularly dilated glands, and the diameter
of the big one might be several or dozens times bigger than that of the small
one. Epithelial cells showed a monolayer or multilayer arrangement. Most
atypical hyperplasia showed a decrease in amount of mucus in the lumen of gland, accompanied
with some degree of
glandular atrophy in most cases and/or with intestinal metaplasia.
②- Adenomatoid atypical hyperplasia: the glands were dilated in moderate
degree, 4 to 6 times that of the normal size, clustered in groups, in back-to-back
or in
conjugated distribution; there were possible presence of intraglandular canula[7],
and a decrease of interstitial, epithelioglandular cells in monolayer
or stratified arrangement, with a decrease of the lumen of gland; there were
also possibly accompanying
glandular atrophy in various degrees, with or without intestinal metaplasia.
Immunohistochemical
staining: there was no P53 expression in simple glandular dilatation
but with positive expression [86%
(5/58)]in
heterotypical glandular dilatation.
The pattern of positive expression demonstrated a focal expression or in some
cells of some dilated glandular ducts, but no positive expression in many
glandular ducts in the same area; on staining density, it refers to a weak Grade
Ⅰ- positive
expression. In view of the expression in adenocarcinoma,
the positive expression was strong, widely distributed and with deep staining,
pertaining to Grade Ⅲ-
or Grade Ⅳ-.
The
PCNA positive expression in simple glandular dilatation
was few in number, which mostly refers to Grade Ⅰ-,
while
the expression with an obvious increase of cell number in heterotye dilatation,
mostly refers to Grade Ⅱ -or Grade Ⅲ-, presenting
a positive expression of many glandular ducts in one area; the positive
expression of PCNA in adenocarcinoma is widely distributed, with rather deep
staining which is mostly referring to an expression
of Grade Ⅲ-
and Grade Ⅳ- (Table 1).
Table 1
P53 and PCNA
expression in 122 cases of gastric mucosa biopsy
| Type | | P53 expression | PCNA expression | ||||
| Number of | - Ⅰ Ⅱ Ⅲ Ⅳ | Positive |
Ⅳ Ⅰ Ⅱ Ⅲ |
||||
| cases | cases | ||||||
| Simple dilatation | 34 | 0 0 0 0 0 | 31(91.2) | 3(8.8) | 0 | 0 | |
| Heterotype dilatation | 27 | 25 2 0 0 0 | 2(7.4) | 4(14.8) | 14(51.9) | 9(333) | 0 |
| Cystadenomatoid | |||||||
| Adenomatoid | 31 | 28 3 0 0 0 | 3(9.7) | 1(3.2) | 13(41.9) | 15(48.4) | 2(6.5) |
| Glandular cancer | 30 | 16 1 3 5 7 | 14(46.7) | 9 | 2(6.7) | 4(13.3) | 21(70.0) |
DISCUSSION
The glandular dilatation of gastric mucosa may be due to many diseases, such
as chronic
atrophic gastritis[8],
gastric polyp[3],
chronic ulcer[9], chronic superficial gastritis and the presence of cancerous gland[10], all of which may be observed characteristically in gastric mucosabiopsy.
It is not a primary disease, but a dilatation with different degrees, forms and
numbers. It is hence suggested that the cystic dilatation of gastric gland and
pyloric gland in deep mucosa covered by the pavement of epithelial cells should
be a sign of alteration of a denatured or atrophic gastritis in advanced
stage, and also that the cystic dilatations occurring in 95% of the early stage
gastric cancers should be a fact closely associated with the cancerous
formation. Some reports dealt with the naming of terms such as cystadeno
dilatation and gastric
adenocyst[4,11].
We believe that in the case of simply involving the
cystic dilatation of glands and inflammatory infiltration, the dilated glands
are small in number and in mild degree, which are possibly defined as simple
glandular dilatation caused by an inflammation or a compressed jan in ducts, not
belonging to a precancerous lesion. However, if there appeared the cystic
dilatation, inflammatory infiltration, and the
dilated glands with great numbers in severe degrees and varied forms, with epithelioglandular
cells in monolayer or stratified arrangement, and nucleus in
varied size, this kind of dilatation would be called the cystadeno-atypicalhyperplasia
because of its cystadeno-structure
and atypical epithelium, which are
recognized as an important precancerous lesion. As for adenomatoid atypical
hyperplasia, on which there had been few reports, the dilated glands are four to
six times that of normal glands in number, clustering in groups, with
interstitial decrease, and back-to-back
or conjugation position, and the epithelioglandular
cells display atypical hyperplasia, accompanied with glandular atrophy or
intestinal metaplasia in various degrees. Because of its adenomatoid structure
and epithelium atypical hyperplasia, it is called adenomatoid atypical
hyperplasia, an important feature of precancerous lesion.
Wild p53 gene is a tumor
suppressor gene, playing a role in control
of cell differentiation,
and preventing the abnormal growth of cells. Because of its short
and unstable halflife, and the low concentration in cells, it can not be
detected by immunohistochemical examinations; mutant p53
gene product, a
more stable protein product accumulated in cells having a loss of its normal
function by extending
its half-life, may inactivate the wild P53, so that the immunohistochemical
assessment becomes a way in research of the genetic alteration of tumor. People
who had excessive P53 protein expression in benign lesion accompanied with
severe degree,
non-typical
epithelium hyperplasia, were later proved to have cancerous
lesion, suggesting that there should be alteration of cells in some
precancerous lesion, which can be expressed in the form of protein level[12]. The expression in samples of gastric mucosa biopsy in our study, is consistent
with previous report. Five cases of atypical glandular dilatation of gastric
mucosa showed a positive expression, but the positive cells were focal in
distribution, while the simple dilatation displayed no expression. The
comparison between atypical glandular dilatation and adenocarcinoma of stomach shows
significant difference (P<0.01),
indicating that P53 occurs in great
number only after occurence of malignant alteration of cells, a transformation from
gastric mucosa to cancer, and a role of great significance in formation of early
cancer.
PCNA is a kind of 36Mr nucleoprotein,
related to the synthesis of DNA in the cell cycle. It seems that the cell is
remaining in an active proliferation state, which, at present has been used as a
criterion for assessment of
malignant potential of a tumor in precancerous stage and
of the dynamics of tumor
cells. In this series of 92 samples of biopsy, the expression in glandular
dilatation of gastric mucosa is increased with the rising of the active level of
the cell proliferation. The comparison between the simple glandular dilatation
and the atypical one is significantly different (P<0.01).
In gastric
cancer, the positive expression is widely distributed and deep in tinction. PCNA
is an important criterion for the diagnosis, classification and treatment of
precancerous lesion.
1Dr. Wang YangKun,
having 59 papers published. Department of Pathology, Chinese
PLA 150 Hospital, Luoyang 471031,
Henan Province, China.
2Dr.
JI Xiao-Long, Department of Pathology, Chinese PLA General Hospital,
Beijing 100853, China.
Correspondence to Dr. Wang Yang
Kun,Department
of Pathology, Chinese
PLA 150 Hospital, Luoyang 471031,
Henan Province, China.
Received -20 October 1995,revised -10 February 1996.